Skip to main content
. 2021 Jul 5;32(10):1047–1061. doi: 10.1007/s10552-021-01472-8

Fig. 4.

Fig. 4

Risk estimates reported for the association between exogenous hormone use and proximal colon cancer by medication type. aEstimates were log-transformed prior to generation of the pooled estimate; bEstimate only age-adjusted; cExcluding Lin 2007 [54] for which no association was found but no risk estimate was reported; dSummary estimate obtained from stratified estimates using random effects meta-analysis methods. CI Confidence interval, HR Hazard Ratio, HRT Hormone Replacement Therapy, I-squared test for heterogeneity, OR Odds Ratio, NR Not reported, p p-value for heterogeneity, R Risk/Rate Ratio